SGN-35
| SGN-35 | |
|---|---|
| Term | SGN-35 |
| Short definition | SGN-35 - A drug used alone or with other drugs to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classical Hodgkin's lymphoma, or mycosis fungoides, and with others Drugs used to treat children from 2 years of age with certain forms of classical Hodgkin's lymphoma. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
SGN-35 - A drug used alone or with other drugs to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classical Hodgkin's lymphoma, or mycosis fungoides, and with others Drugs used to treat children from 2 years of age with certain forms of classical Hodgkin's lymphoma. It is also being studied in the treatment of other types of cancer. SGN-35 contains a monoclonal antibody that binds to a protein called CD30 found on some lymphoma cells. It also contains a cancer drug that can help kill cancer cells. SGN-35 is a type of antibody-drug conjugate. Also called Adcetris and Brentuximab Vedotin
External links
- Medical encyclopedia article on SGN-35
- Wikipedia's article - SGN-35
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski